Motif ID: Maz_Zfp281
Z-value: 1.745
Transcription factors associated with Maz_Zfp281:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Maz | ENSMUSG00000030678.6 | Maz |
Zfp281 | ENSMUSG00000041483.8 | Zfp281 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Maz | mm10_v2_chr7_-_127026479_127026496 | 0.74 | 1.2e-10 | Click! |
Zfp281 | mm10_v2_chr1_+_136624901_136624949 | 0.21 | 1.3e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 37.0 | GO:0097402 | neuroblast migration(GO:0097402) |
10.1 | 30.2 | GO:0030421 | defecation(GO:0030421) |
9.2 | 27.6 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
8.9 | 26.8 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
6.2 | 18.6 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
6.2 | 18.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
6.1 | 30.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
5.8 | 23.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
5.8 | 5.8 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
5.6 | 5.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
5.3 | 15.8 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
5.2 | 10.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
5.1 | 20.4 | GO:0060032 | notochord regression(GO:0060032) |
4.9 | 9.8 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
4.8 | 29.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
4.8 | 24.1 | GO:0048382 | mesendoderm development(GO:0048382) |
4.7 | 18.7 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
4.4 | 13.3 | GO:0060166 | olfactory pit development(GO:0060166) |
4.3 | 4.3 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
4.3 | 12.8 | GO:0003360 | brainstem development(GO:0003360) |
4.1 | 12.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
4.0 | 4.0 | GO:0090194 | negative regulation of glomerular mesangial cell proliferation(GO:0072125) negative regulation of glomerulus development(GO:0090194) |
3.9 | 3.9 | GO:0045608 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.9 | 11.6 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
3.9 | 15.4 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
3.7 | 7.4 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
3.7 | 11.0 | GO:0072034 | renal vesicle induction(GO:0072034) |
3.6 | 10.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
3.6 | 35.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
3.6 | 10.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
3.5 | 7.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.4 | 23.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.3 | 10.0 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
3.3 | 9.8 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
3.2 | 9.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.2 | 9.7 | GO:0014028 | notochord formation(GO:0014028) |
3.2 | 9.6 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.2 | 22.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.2 | 12.7 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
3.2 | 3.2 | GO:1903463 | regulation of mitotic cell cycle DNA replication(GO:1903463) |
3.2 | 12.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
3.1 | 12.5 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
3.1 | 21.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
3.1 | 18.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.0 | 9.1 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
3.0 | 15.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
2.9 | 35.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.9 | 14.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.8 | 8.4 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
2.7 | 10.8 | GO:0015705 | iodide transport(GO:0015705) |
2.7 | 16.1 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
2.7 | 8.0 | GO:0007494 | midgut development(GO:0007494) |
2.6 | 7.9 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
2.6 | 7.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.6 | 7.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
2.6 | 13.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
2.6 | 7.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.6 | 5.1 | GO:0072049 | comma-shaped body morphogenesis(GO:0072049) |
2.5 | 7.6 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.5 | 7.6 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.5 | 7.6 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.5 | 5.0 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
2.5 | 10.0 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
2.5 | 27.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
2.5 | 5.0 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
2.4 | 7.3 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
2.4 | 23.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
2.3 | 7.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.3 | 9.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.3 | 4.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
2.3 | 6.8 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
2.2 | 31.2 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) |
2.2 | 2.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
2.2 | 4.4 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
2.2 | 8.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
2.2 | 15.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
2.2 | 8.6 | GO:0030091 | protein repair(GO:0030091) |
2.1 | 21.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
2.1 | 4.2 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
2.1 | 44.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.1 | 10.4 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
2.1 | 20.6 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
2.1 | 8.2 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
2.0 | 16.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.0 | 10.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
2.0 | 6.0 | GO:0021764 | amygdala development(GO:0021764) |
2.0 | 4.0 | GO:0021759 | globus pallidus development(GO:0021759) |
2.0 | 8.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
2.0 | 4.0 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
2.0 | 5.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.0 | 5.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
2.0 | 7.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.9 | 13.5 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
1.9 | 11.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.9 | 17.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.9 | 9.5 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.9 | 3.8 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.9 | 1.9 | GO:0021603 | cranial nerve formation(GO:0021603) |
1.9 | 20.6 | GO:0060539 | diaphragm development(GO:0060539) |
1.9 | 3.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.9 | 15.0 | GO:0097421 | liver regeneration(GO:0097421) |
1.9 | 18.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.9 | 1.9 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.8 | 5.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.8 | 5.5 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
1.8 | 7.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
1.8 | 5.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
1.8 | 9.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.8 | 9.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
1.8 | 19.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.8 | 5.3 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
1.7 | 7.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.7 | 10.4 | GO:0044351 | macropinocytosis(GO:0044351) |
1.7 | 5.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
1.7 | 5.1 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.7 | 3.4 | GO:0009583 | detection of light stimulus(GO:0009583) |
1.7 | 15.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.7 | 13.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
1.7 | 5.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
1.7 | 1.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.7 | 6.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.7 | 6.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.7 | 9.9 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
1.6 | 6.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.6 | 6.5 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.6 | 3.3 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
1.6 | 6.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.6 | 1.6 | GO:0032817 | regulation of natural killer cell proliferation(GO:0032817) positive regulation of natural killer cell proliferation(GO:0032819) |
1.6 | 8.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
1.6 | 6.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.6 | 1.6 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.6 | 3.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.6 | 6.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.6 | 4.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.6 | 15.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
1.6 | 9.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.6 | 4.7 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
1.5 | 1.5 | GO:0009880 | embryonic pattern specification(GO:0009880) |
1.5 | 4.6 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.5 | 4.6 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
1.5 | 6.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.5 | 3.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.5 | 1.5 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
1.5 | 4.5 | GO:0006116 | NADH oxidation(GO:0006116) |
1.5 | 4.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.5 | 7.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
1.5 | 9.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.5 | 1.5 | GO:0002063 | chondrocyte development(GO:0002063) |
1.5 | 3.0 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
1.5 | 1.5 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.5 | 8.9 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.5 | 1.5 | GO:0042440 | pigment metabolic process(GO:0042440) |
1.5 | 10.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.5 | 4.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.5 | 8.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.5 | 5.8 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
1.5 | 4.4 | GO:0019405 | alditol catabolic process(GO:0019405) |
1.5 | 5.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.4 | 13.0 | GO:0072189 | ureter development(GO:0072189) |
1.4 | 4.3 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
1.4 | 30.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.4 | 1.4 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.4 | 2.9 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
1.4 | 2.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.4 | 22.7 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
1.4 | 8.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
1.4 | 1.4 | GO:0072235 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
1.4 | 11.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.4 | 5.6 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
1.4 | 1.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.4 | 1.4 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.4 | 8.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
1.4 | 15.3 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
1.4 | 2.8 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
1.4 | 5.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.4 | 9.6 | GO:0001842 | neural fold formation(GO:0001842) |
1.4 | 1.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
1.4 | 8.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.4 | 12.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.4 | 6.8 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.4 | 4.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
1.3 | 4.0 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
1.3 | 6.7 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.3 | 12.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
1.3 | 4.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
1.3 | 1.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.3 | 9.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 3.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.3 | 3.9 | GO:0019230 | proprioception(GO:0019230) |
1.3 | 11.7 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
1.3 | 9.1 | GO:0043586 | tongue development(GO:0043586) |
1.3 | 3.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.3 | 2.5 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
1.3 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.3 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.3 | 5.1 | GO:0070269 | pyroptosis(GO:0070269) |
1.3 | 3.8 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.2 | 8.7 | GO:0072070 | loop of Henle development(GO:0072070) |
1.2 | 3.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.2 | 2.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.2 | 3.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.2 | 3.7 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
1.2 | 2.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.2 | 2.4 | GO:2000096 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.2 | 1.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
1.2 | 2.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.2 | 2.4 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
1.2 | 7.1 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.2 | 22.4 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.2 | 21.1 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
1.2 | 2.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
1.2 | 5.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.2 | 8.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.2 | 4.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
1.2 | 1.2 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.2 | 5.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.1 | 1.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
1.1 | 1.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
1.1 | 3.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.1 | 1.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.1 | 7.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.1 | 3.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.1 | 7.9 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.1 | 4.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.1 | 8.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.1 | 11.1 | GO:0001675 | acrosome assembly(GO:0001675) |
1.1 | 5.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.1 | 4.4 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 5.5 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.1 | 8.8 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
1.1 | 2.2 | GO:0036292 | DNA rewinding(GO:0036292) |
1.1 | 4.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.1 | 11.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.1 | 6.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.1 | 4.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
1.1 | 3.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.1 | 1.1 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
1.1 | 7.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.1 | 7.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.1 | 12.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.1 | 2.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.1 | 7.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
1.1 | 1.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
1.1 | 2.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
1.1 | 5.3 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
1.1 | 5.3 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.1 | 3.2 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.0 | 3.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
1.0 | 2.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.0 | 10.4 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
1.0 | 2.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.0 | 1.0 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
1.0 | 2.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.0 | 4.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.0 | 2.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
1.0 | 3.0 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.0 | 7.1 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
1.0 | 4.0 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 3.0 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.0 | 3.0 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
1.0 | 3.0 | GO:2000053 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
1.0 | 3.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.0 | 3.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.0 | 1.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.0 | 8.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
1.0 | 4.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.0 | 22.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.0 | 4.9 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
1.0 | 2.9 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.0 | 4.8 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.0 | 3.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.9 | 5.7 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.9 | 9.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 3.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 1.9 | GO:0035989 | tendon development(GO:0035989) |
0.9 | 2.8 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 | 0.9 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
0.9 | 6.5 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.9 | 0.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.9 | 3.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 2.8 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.9 | 2.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.9 | 4.6 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.9 | 1.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.9 | 1.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.9 | 16.4 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.9 | 6.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.9 | 0.9 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.9 | 1.8 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.9 | 2.7 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.9 | 3.6 | GO:0015867 | ATP transport(GO:0015867) |
0.9 | 1.8 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.9 | 3.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.9 | 3.5 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.9 | 2.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.9 | 2.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.9 | 1.8 | GO:0043921 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
0.9 | 2.6 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.9 | 5.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.9 | 1.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.9 | 4.3 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.9 | 6.0 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.9 | 8.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.9 | 3.4 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.9 | 2.6 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.9 | 5.1 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 5.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 4.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 1.7 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.8 | 1.7 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.8 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 4.2 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.8 | 2.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.8 | 1.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.8 | 6.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.8 | 4.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.8 | 1.6 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.8 | 6.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.8 | 0.8 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.8 | 3.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.8 | 2.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.8 | 3.9 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.8 | 3.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.8 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 8.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.8 | 6.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.8 | 3.8 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.8 | 0.8 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.8 | 0.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.8 | 8.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.8 | 3.0 | GO:0048664 | neuron fate determination(GO:0048664) |
0.8 | 3.8 | GO:0051026 | chiasma assembly(GO:0051026) |
0.8 | 2.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.8 | 0.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.7 | 1.5 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.7 | 1.5 | GO:1901355 | response to rapamycin(GO:1901355) |
0.7 | 7.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 4.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.7 | 0.7 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) regulation of cell junction assembly(GO:1901888) |
0.7 | 5.9 | GO:0040031 | snRNA modification(GO:0040031) |
0.7 | 4.4 | GO:0070836 | caveola assembly(GO:0070836) |
0.7 | 4.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 1.5 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.7 | 2.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.7 | 6.5 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 24.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 2.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.7 | 1.4 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.7 | 2.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 2.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.7 | 4.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 1.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.7 | 2.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.7 | 4.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.7 | 4.9 | GO:0010273 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.7 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.7 | 5.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.7 | 1.4 | GO:0007140 | male meiosis(GO:0007140) |
0.7 | 4.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 6.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.7 | 2.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.7 | 1.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 3.4 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
0.7 | 12.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.7 | 1.4 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.7 | 1.4 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.7 | 0.7 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.7 | 12.8 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.7 | 9.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.7 | 2.0 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.7 | 2.0 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.7 | 2.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.7 | 4.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.7 | 3.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.7 | 0.7 | GO:0033083 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.7 | 2.0 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.7 | 8.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 3.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.7 | 2.0 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.7 | 21.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.7 | 2.0 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.7 | 0.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.6 | 5.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
0.6 | 10.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 1.3 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.6 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.6 | 4.5 | GO:0006971 | hypotonic response(GO:0006971) |
0.6 | 3.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.6 | 1.3 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.6 | 1.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.6 | 3.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.6 | 5.7 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.6 | 3.2 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.6 | 3.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.6 | 2.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.6 | 1.9 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.6 | 4.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 2.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.6 | 3.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.6 | 6.3 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.6 | 3.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.6 | 3.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.6 | 2.5 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 1.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.6 | 1.9 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.6 | 11.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.6 | 2.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.6 | 4.9 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 7.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.6 | 6.1 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.6 | 15.3 | GO:0021915 | neural tube development(GO:0021915) |
0.6 | 2.4 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 1.2 | GO:0060923 | muscle cell fate commitment(GO:0042693) cardiac muscle cell fate commitment(GO:0060923) |
0.6 | 3.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 3.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.6 | 0.6 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.6 | 0.6 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.6 | 1.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.6 | 5.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.6 | 13.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.6 | 7.8 | GO:0007530 | sex determination(GO:0007530) |
0.6 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.6 | 2.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 0.6 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.6 | 2.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.6 | 1.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 2.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.6 | 1.2 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 5.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 12.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.6 | 1.2 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.6 | 2.9 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.6 | 3.5 | GO:0043584 | nose development(GO:0043584) |
0.6 | 1.7 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.6 | 2.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 4.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 2.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.6 | 4.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.6 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.6 | 3.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.6 | 1.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.6 | 1.7 | GO:0015840 | urea transport(GO:0015840) |
0.6 | 1.7 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.6 | 2.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.6 | 0.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.5 | 2.7 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.5 | 3.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.5 | 2.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 2.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 1.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.5 | 1.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.5 | 0.5 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 2.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
0.5 | 1.1 | GO:1990839 | response to endothelin(GO:1990839) |
0.5 | 0.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.5 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.5 | 2.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 1.1 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 1.6 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 1.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 3.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.5 | 1.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 8.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.5 | 1.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.5 | 3.1 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
0.5 | 1.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 4.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 1.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.5 | 2.6 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 2.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 2.5 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 4.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 3.5 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 3.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.5 | 3.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 2.0 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
0.5 | 1.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.5 | 1.5 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.5 | 2.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 1.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.5 | 4.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.5 | 0.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.5 | 2.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.5 | 1.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.5 | 3.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 0.5 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.5 | 1.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.5 | 1.4 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.5 | 1.4 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.5 | 4.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 0.9 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.5 | 3.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 0.9 | GO:0071649 | chemokine (C-C motif) ligand 5 production(GO:0071609) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.5 | 0.9 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.5 | 6.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.5 | 0.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.5 | 1.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.5 | 2.3 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.5 | 1.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.5 | 1.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 0.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.5 | 0.5 | GO:1905076 | regulation of interleukin-17 secretion(GO:1905076) |
0.5 | 8.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 1.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.5 | 16.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.4 | 0.9 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.4 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 1.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.4 | 3.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.4 | 3.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 4.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 0.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.4 | 0.4 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.4 | 1.3 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 3.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 2.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.4 | 1.3 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 6.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.4 | 0.4 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.4 | 0.4 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 1.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.4 | 1.3 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.4 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 3.8 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.4 | 0.4 | GO:0048021 | regulation of secondary metabolic process(GO:0043455) regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.4 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.4 | 1.7 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.4 | 1.3 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.4 | 2.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.4 | 1.6 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.4 | 2.0 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.4 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.4 | 2.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 1.6 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.4 | 2.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.4 | 1.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.4 | 6.1 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.4 | 0.8 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 2.8 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.4 | 0.4 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) pattern specification involved in metanephros development(GO:0072268) |
0.4 | 1.2 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.4 | 1.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.4 | 3.5 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.4 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 2.7 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 7.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.4 | 2.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.5 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.4 | 4.6 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 2.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 5.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 2.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.8 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.4 | 1.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.4 | 1.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.4 | 0.7 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.4 | 1.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.4 | 3.7 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.4 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) regulation of keratinocyte differentiation(GO:0045616) |
0.4 | 3.7 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 1.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 2.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.1 | GO:1901675 | response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.4 | 0.4 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.4 | 1.8 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
0.4 | 2.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.4 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.4 | 1.4 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.4 | 7.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.4 | 0.4 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.4 | 2.1 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.4 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.4 | 0.4 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.4 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.4 | 0.7 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.4 | 1.8 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.3 | 3.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 4.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.3 | 1.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.3 | 3.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) mesonephric tubule morphogenesis(GO:0072171) |
0.3 | 0.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.3 | 1.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.0 | GO:0010814 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.3 | 1.0 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.3 | 0.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 1.6 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 3.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.3 | 0.7 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.3 | 1.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 4.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 1.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 2.6 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.3 | 3.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 3.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.3 | 0.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.3 | 1.6 | GO:0015822 | ornithine transport(GO:0015822) |
0.3 | 0.3 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
0.3 | 2.5 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.3 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.3 | 0.9 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.3 | 3.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 0.9 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.3 | 0.3 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) establishment of skin barrier(GO:0061436) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 2.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 3.1 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 0.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.9 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.3 | 2.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 0.6 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.3 | 7.6 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.3 | 0.9 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 0.6 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.9 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.3 | 3.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 5.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 3.3 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.3 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.3 | 1.2 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.3 | 0.3 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 2.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.3 | 1.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 2.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.3 | 1.7 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 2.9 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.3 | 3.8 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.3 | 1.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.3 | 0.9 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.3 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 7.4 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.3 | 1.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 1.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.3 | 1.1 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.3 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 0.8 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 1.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.8 | GO:0071372 | response to follicle-stimulating hormone(GO:0032354) response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 0.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.3 | 0.8 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.3 | 0.3 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.3 | 1.1 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.3 | 3.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 1.1 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
0.3 | 1.4 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.3 | 2.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.5 | GO:1990523 | bone regeneration(GO:1990523) |
0.3 | 2.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.8 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
0.3 | 0.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.3 | 0.8 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.3 | 0.5 | GO:0021983 | pituitary gland development(GO:0021983) |
0.3 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.3 | 0.5 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.3 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.3 | 1.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 0.8 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.3 | 1.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 2.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.3 | 0.3 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.3 | 0.8 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.3 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.3 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 2.3 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.3 | 0.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.3 | 0.5 | GO:0010920 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
0.3 | 0.3 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 0.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 1.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.3 | 3.3 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.3 | 2.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 4.5 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.2 | 1.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.7 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.2 | 0.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 0.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 0.7 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
0.2 | 2.5 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 9.2 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 0.7 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 1.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 3.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.5 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 0.2 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.2 | 2.9 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.2 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.2 | 0.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.2 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.2 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 6.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.7 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 11.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 4.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.2 | 2.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 1.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.9 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.2 | 0.7 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.2 | 1.6 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.2 | 0.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.2 | 3.9 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.2 | 2.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.2 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.2 | 1.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 1.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.1 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.2 | 21.5 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 9.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 1.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 2.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.2 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 0.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.2 | 0.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.9 | GO:0007320 | insemination(GO:0007320) |
0.2 | 1.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 5.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.7 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 2.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.2 | 0.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.2 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.8 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.2 | 0.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 1.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 4.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.7 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 1.7 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 0.4 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.8 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.2 | 1.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.4 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.2 | 2.6 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 2.6 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.2 | 2.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 1.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.4 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.2 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 1.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 9.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 0.2 | GO:0035092 | spermatid nucleus differentiation(GO:0007289) sperm chromatin condensation(GO:0035092) |
0.2 | 0.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 2.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 2.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.2 | 1.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 5.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.2 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 2.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 5.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 1.0 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.4 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 2.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.2 | 0.7 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 1.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 1.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 4.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.6 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.2 | 2.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 0.5 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 2.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 0.2 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 0.2 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.2 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 0.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 0.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 1.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.2 | 3.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.2 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 0.2 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 1.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 1.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 2.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 2.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 0.8 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.2 | 1.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 0.2 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 2.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.8 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.2 | 0.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.2 | 0.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.2 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.2 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 0.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 4.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.6 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.3 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.2 | 0.3 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.2 | 2.4 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.2 | 0.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.2 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 4.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.3 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.1 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.1 | 0.3 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 2.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.8 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.6 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 2.7 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 1.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 3.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 1.8 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.7 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.1 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.5 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 3.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 2.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.4 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.3 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 2.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.4 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.6 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.4 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.1 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.4 | GO:0045006 | DNA deamination(GO:0045006) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 9.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 1.0 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 0.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.6 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.1 | 0.8 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.2 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.1 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 2.1 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 1.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.2 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
0.1 | 0.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.1 | 0.6 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.3 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
0.1 | 0.3 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0045091 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.6 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 1.7 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.4 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 2.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.4 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.9 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:0001736 | establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
0.1 | 0.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 4.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 2.3 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.1 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.1 | 1.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.8 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.1 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.1 | 1.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.1 | 0.1 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.3 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 1.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 1.8 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 1.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.9 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.4 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.1 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.6 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 1.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 2.5 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.1 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.1 | 0.6 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 2.5 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.1 | GO:0045580 | regulation of T cell differentiation(GO:0045580) |
0.1 | 0.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.2 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.9 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.1 | 0.2 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) secondary metabolite biosynthetic process(GO:0044550) pigment biosynthetic process(GO:0046148) |
0.1 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.4 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.3 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 2.1 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.9 | GO:0046661 | male sex differentiation(GO:0046661) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.7 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.0 | 0.0 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.0 | 0.2 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.0 | 0.2 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.0 | GO:0045058 | T cell selection(GO:0045058) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) regulation of cytokine secretion involved in immune response(GO:0002739) positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.2 | GO:0003416 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) |
0.0 | 0.0 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.0 | 0.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.5 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.2 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.1 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.3 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.0 | 0.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.4 | GO:0060746 | parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.0 | 8.5 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 1.5 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:1901988 | negative regulation of cell cycle phase transition(GO:1901988) |
0.0 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.6 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.0 | 0.2 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.0 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.6 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.1 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 0.1 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 13.3 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
4.3 | 12.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
4.1 | 12.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
3.9 | 11.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.8 | 15.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
3.4 | 16.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
3.3 | 19.5 | GO:0031262 | Ndc80 complex(GO:0031262) |
2.8 | 14.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.8 | 8.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.8 | 30.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.8 | 8.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.7 | 5.4 | GO:0071953 | elastic fiber(GO:0071953) |
2.5 | 10.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.5 | 7.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.4 | 9.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
2.2 | 15.4 | GO:0001740 | Barr body(GO:0001740) |
2.2 | 6.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
2.0 | 12.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.8 | 14.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
1.7 | 8.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.7 | 5.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
1.7 | 10.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.6 | 11.0 | GO:0097452 | GAIT complex(GO:0097452) |
1.6 | 18.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.5 | 7.7 | GO:0005861 | troponin complex(GO:0005861) |
1.5 | 6.0 | GO:0008623 | CHRAC(GO:0008623) |
1.5 | 8.9 | GO:0035976 | AP1 complex(GO:0035976) |
1.5 | 16.3 | GO:0005915 | zonula adherens(GO:0005915) |
1.5 | 4.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 4.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.4 | 5.7 | GO:0060187 | cell pole(GO:0060187) |
1.4 | 18.1 | GO:0097542 | ciliary tip(GO:0097542) |
1.4 | 5.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
1.4 | 5.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.4 | 4.1 | GO:0016600 | flotillin complex(GO:0016600) |
1.3 | 5.2 | GO:0014802 | terminal cisterna(GO:0014802) |
1.3 | 1.3 | GO:0044301 | climbing fiber(GO:0044301) |
1.3 | 2.6 | GO:0042585 | germinal vesicle(GO:0042585) |
1.3 | 5.1 | GO:0061702 | inflammasome complex(GO:0061702) |
1.2 | 24.4 | GO:0010369 | chromocenter(GO:0010369) |
1.2 | 4.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 3.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
1.1 | 4.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
1.1 | 3.3 | GO:0071564 | npBAF complex(GO:0071564) |
1.1 | 4.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.0 | 6.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 9.0 | GO:0000796 | condensin complex(GO:0000796) |
1.0 | 12.9 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 48.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.0 | 1.0 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.9 | 69.0 | GO:0005844 | polysome(GO:0005844) |
0.9 | 5.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 5.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.9 | 3.7 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.9 | 9.3 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 2.7 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.9 | 5.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 1.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.9 | 16.6 | GO:0097470 | ribbon synapse(GO:0097470) |
0.9 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.8 | 3.4 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 4.2 | GO:0072487 | MSL complex(GO:0072487) |
0.8 | 5.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.8 | 8.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 8.1 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 38.7 | GO:0000791 | euchromatin(GO:0000791) |
0.8 | 13.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.8 | 3.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.8 | 2.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.8 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 6.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 2.3 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.7 | 9.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.7 | 15.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.7 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.7 | 8.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.7 | 2.0 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
0.7 | 2.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 2.0 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 9.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.7 | 6.0 | GO:0045120 | pronucleus(GO:0045120) |
0.7 | 3.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 3.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.7 | 2.0 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.6 | 3.9 | GO:0043256 | laminin complex(GO:0043256) |
0.6 | 1.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.6 | 5.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.6 | 4.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.6 | 2.5 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 11.9 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.6 | 2.5 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 10.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.6 | 4.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.6 | 3.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 3.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.6 | 1.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.6 | 0.6 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.6 | 11.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 2.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.6 | 2.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 4.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.5 | 3.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 4.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 3.8 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.5 | 6.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 5.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 2.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 2.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.5 | 1.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 6.5 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 2.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 2.0 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.5 | 2.4 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 4.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.5 | 6.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.5 | 5.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.5 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 4.8 | GO:0031105 | septin complex(GO:0031105) |
0.5 | 5.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.5 | 2.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.5 | 3.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.5 | 10.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.5 | 6.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 1.4 | GO:0071914 | prominosome(GO:0071914) |
0.5 | 181.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.5 | 3.7 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.5 | 1.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 3.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.4 | 2.6 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 5.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 3.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.4 | 2.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.4 | 8.0 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.4 | 5.9 | GO:0051286 | cell tip(GO:0051286) |
0.4 | 7.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.4 | 2.5 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 40.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 5.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 0.4 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.4 | 1.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 3.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.4 | 3.5 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.4 | 2.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.4 | 2.7 | GO:0031415 | NatA complex(GO:0031415) |
0.4 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.4 | 8.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.4 | 5.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 5.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.4 | 1.5 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.4 | 0.8 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.4 | 18.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.4 | 5.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 0.4 | GO:0034358 | plasma lipoprotein particle(GO:0034358) very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) lipoprotein particle(GO:1990777) |
0.4 | 2.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 2.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.4 | 1.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.4 | 10.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 2.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 2.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.4 | 3.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 2.5 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 1.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 5.9 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 1.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 1.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 8.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 1.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 3.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 21.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 3.5 | GO:0098687 | chromosomal region(GO:0098687) |
0.3 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.3 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 2.4 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 10.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 4.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 5.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.3 | 1.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.3 | 4.0 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.3 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 0.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 15.2 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 1.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.3 | 3.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 1.9 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.3 | 1.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 2.0 | GO:0043034 | costamere(GO:0043034) |
0.3 | 0.8 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.3 | 5.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 1.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.3 | 2.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 2.0 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.3 | 2.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 13.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.2 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 2.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 2.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 3.3 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 1.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 1.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.2 | 8.1 | GO:0002102 | podosome(GO:0002102) |
0.2 | 12.3 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 6.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 2.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 25.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 2.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.9 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.9 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.2 | 2.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 3.9 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 3.6 | GO:0001741 | XY body(GO:0001741) |
0.2 | 13.6 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 10.0 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 5.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 0.6 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.2 | 2.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 0.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 5.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 0.7 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.2 | 1.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.2 | GO:0071920 | cleavage body(GO:0071920) |
0.2 | 0.2 | GO:0031430 | M band(GO:0031430) |
0.2 | 2.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.3 | GO:0016234 | inclusion body(GO:0016234) |
0.2 | 0.7 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.2 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 1.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 0.5 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 0.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 5.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 0.6 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 4.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 5.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.2 | 3.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 4.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 0.7 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 7.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 26.0 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.1 | 1.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.5 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.1 | 2.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.9 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.6 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 10.7 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.4 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 4.2 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 17.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 6.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 1.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 578.0 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.8 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 0.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 5.4 | GO:0070160 | occluding junction(GO:0070160) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 1.5 | GO:0030286 | dynein complex(GO:0030286) |
0.1 | 2.3 | GO:0015934 | large ribosomal subunit(GO:0015934) cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 2.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 6.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 0.2 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 7.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.4 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 3.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.5 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.0 | 0.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 2.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.2 | GO:0043233 | organelle lumen(GO:0043233) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 25.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
4.4 | 26.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
4.3 | 13.0 | GO:0070052 | collagen V binding(GO:0070052) |
4.1 | 12.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
3.7 | 14.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
3.7 | 3.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
3.5 | 24.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.4 | 13.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
3.2 | 25.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
3.2 | 12.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.9 | 11.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
2.8 | 11.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.8 | 16.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
2.8 | 8.3 | GO:0035939 | microsatellite binding(GO:0035939) |
2.7 | 43.8 | GO:0003680 | AT DNA binding(GO:0003680) |
2.7 | 10.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
2.6 | 10.6 | GO:0008142 | oxysterol binding(GO:0008142) |
2.6 | 13.1 | GO:0043515 | kinetochore binding(GO:0043515) |
2.6 | 10.3 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.6 | 10.3 | GO:0004064 | arylesterase activity(GO:0004064) |
2.5 | 10.1 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
2.5 | 7.5 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
2.4 | 9.8 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
2.4 | 19.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.4 | 14.6 | GO:0019841 | retinol binding(GO:0019841) |
2.4 | 7.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
2.3 | 6.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
2.3 | 9.1 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
2.2 | 15.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.2 | 19.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.2 | 8.7 | GO:1990254 | keratin filament binding(GO:1990254) |
2.2 | 2.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.2 | 17.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
2.1 | 10.5 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
2.1 | 6.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
1.9 | 9.7 | GO:0050693 | LBD domain binding(GO:0050693) |
1.9 | 3.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.8 | 5.5 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
1.8 | 5.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.7 | 8.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.6 | 37.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
1.6 | 17.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.6 | 6.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.6 | 7.8 | GO:0005113 | patched binding(GO:0005113) |
1.5 | 3.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.5 | 35.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.5 | 7.7 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 12.2 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.5 | 36.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
1.5 | 16.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.5 | 1.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.5 | 12.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.5 | 13.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.5 | 4.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
1.5 | 13.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.5 | 4.4 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.5 | 7.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.4 | 8.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.4 | 18.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.4 | 4.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.4 | 15.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.4 | 9.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
1.3 | 4.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.3 | 3.9 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
1.3 | 14.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.3 | 5.0 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
1.3 | 5.0 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
1.2 | 6.2 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 5.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
1.2 | 21.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.2 | 12.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 3.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
1.2 | 7.2 | GO:0043426 | MRF binding(GO:0043426) |
1.2 | 9.6 | GO:0031432 | titin binding(GO:0031432) |
1.2 | 9.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.2 | 2.4 | GO:0034046 | poly(G) binding(GO:0034046) |
1.2 | 9.6 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.2 | 5.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.2 | 3.5 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.2 | 5.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.2 | 5.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 3.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 1.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.2 | 9.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 4.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.1 | 5.7 | GO:0038132 | neuregulin binding(GO:0038132) |
1.1 | 8.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.1 | 29.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.1 | 11.3 | GO:0035198 | miRNA binding(GO:0035198) |
1.1 | 4.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.1 | 4.3 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
1.1 | 10.7 | GO:0019956 | chemokine binding(GO:0019956) |
1.1 | 3.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
1.1 | 5.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.1 | 2.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.1 | 3.2 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
1.1 | 6.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.0 | 4.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
1.0 | 3.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.0 | 4.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.0 | 5.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.0 | 1.0 | GO:0003681 | bent DNA binding(GO:0003681) |
1.0 | 3.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.0 | 4.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 4.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.0 | 2.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.0 | 6.9 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
1.0 | 6.8 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.0 | 33.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.0 | 12.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 7.8 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
1.0 | 2.9 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
1.0 | 6.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 2.9 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.9 | 13.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.9 | 3.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 6.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.9 | 0.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.9 | 3.7 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.9 | 51.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.9 | 6.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.9 | 6.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.9 | 10.9 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 8.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.9 | 3.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.9 | 5.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.9 | 23.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.9 | 22.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 7.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 69.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.9 | 7.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 4.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.9 | 4.3 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.9 | 4.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 6.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.8 | 27.5 | GO:0070888 | E-box binding(GO:0070888) |
0.8 | 2.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.8 | 14.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.8 | 3.2 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.8 | 3.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.8 | 13.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.8 | 23.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.8 | 5.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.8 | 53.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.8 | 5.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.8 | 2.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 2.3 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.8 | 1.5 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.8 | 3.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 9.2 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 2.3 | GO:0031208 | POZ domain binding(GO:0031208) |
0.8 | 2.3 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.7 | 14.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 2.2 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.7 | 15.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.7 | 6.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.7 | 8.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 4.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.7 | 4.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.7 | 2.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.7 | 0.7 | GO:0004096 | catalase activity(GO:0004096) |
0.7 | 2.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 4.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.7 | 11.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 1.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 8.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 8.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.7 | 6.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.7 | 2.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.7 | 2.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.7 | 2.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.7 | 26.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 2.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 2.6 | GO:2001069 | glycogen binding(GO:2001069) |
0.7 | 2.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.7 | 3.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 1.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.6 | 2.5 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.6 | 2.5 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.6 | 8.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.6 | 1.9 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 17.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 1.8 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.6 | 6.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 1.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 6.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.6 | 78.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.6 | 2.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.6 | 2.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.6 | 1.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.6 | 2.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 0.6 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.6 | 2.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.6 | 11.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 5.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.6 | 2.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 4.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 6.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.6 | 3.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.6 | 1.7 | GO:0019842 | vitamin binding(GO:0019842) |
0.6 | 1.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 6.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.6 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 2.2 | GO:0070279 | vitamin B6 binding(GO:0070279) |
0.5 | 2.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.6 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 2.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.5 | 1.6 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.5 | 3.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 2.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.5 | 10.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.5 | 2.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 10.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 11.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.5 | 155.1 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.5 | 2.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.5 | 2.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 4.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 1.5 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.5 | 2.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.5 | 8.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 2.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.5 | 10.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.5 | 15.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 4.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 3.8 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.5 | 2.9 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.5 | 3.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.5 | 5.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.5 | 2.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.5 | 4.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.5 | 2.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.5 | 1.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 3.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.5 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.5 | 3.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 5.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.4 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.5 | 2.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.4 | 2.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.4 | 2.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 0.9 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.4 | 4.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 6.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 3.1 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 3.5 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 2.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.4 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.4 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.4 | 5.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 2.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 5.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.4 | 0.8 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 1.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.2 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.4 | 2.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.4 | 1.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.4 | 2.8 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 1.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.4 | 3.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 12.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.4 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 21.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.4 | 3.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.4 | 2.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 4.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 0.7 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 2.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 2.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 1.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.4 | 0.7 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.4 | 3.6 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 3.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 11.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.3 | 1.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.3 | 3.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.3 | 146.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.3 | 1.0 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.3 | 2.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 2.0 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.3 | 0.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 6.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 5.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 3.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 2.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.3 | 4.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 1.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 4.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 1.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 0.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.3 | 6.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 0.6 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 2.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 3.3 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.3 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.9 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 1.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.3 | 2.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 2.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 2.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 0.9 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.3 | 0.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 3.4 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 2.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.3 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 1.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 0.3 | GO:0070404 | NADH binding(GO:0070404) |
0.3 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 4.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 4.0 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 1.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 2.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.3 | 4.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) cytosine C-5 DNA demethylase activity(GO:0051747) |
0.3 | 0.8 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.3 | 2.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.3 | 0.8 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.2 | 0.5 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.2 | 1.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 6.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.2 | 3.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 7.6 | GO:0001067 | regulatory region nucleic acid binding(GO:0001067) |
0.2 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.0 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 4.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 1.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.2 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 23.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.2 | 0.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 2.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 1.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.2 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 4.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 0.9 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.2 | 0.9 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.2 | 2.8 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 0.6 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 4.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 0.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 5.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 11.9 | GO:0004386 | helicase activity(GO:0004386) |
0.2 | 19.8 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 5.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.2 | 2.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 0.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 6.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 2.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 5.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 4.4 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.6 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 2.3 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 4.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.2 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 22.8 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.9 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 16.0 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 1.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.2 | 0.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 3.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.5 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.5 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.2 | 0.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 0.5 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 1.5 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 3.3 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 2.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 1.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 2.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 2.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.2 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.5 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.4 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.1 | 4.5 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.3 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.1 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 6.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 9.4 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 7.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.9 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 4.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.8 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.1 | 1.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.1 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 0.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 1.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 3.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 4.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 1.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 2.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 3.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.6 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 8.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.7 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 2.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 55.2 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.4 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.7 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 5.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 2.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.6 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.1 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.1 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 8.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.4 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.8 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.2 | GO:0070976 | TIR domain binding(GO:0070976) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 1.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 1.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.4 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.0 | 0.3 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.0 | 0.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.0 | GO:0005118 | sevenless binding(GO:0005118) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 49.0 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
2.7 | 2.7 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
1.6 | 14.2 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.3 | 41.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
1.3 | 5.1 | ST_ADRENERGIC | Adrenergic Pathway |
1.3 | 60.8 | PID_AURORA_B_PATHWAY | Aurora B signaling |
1.2 | 35.4 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
1.2 | 55.3 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
1.1 | 18.9 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
0.9 | 48.0 | PID_BMP_PATHWAY | BMP receptor signaling |
0.9 | 10.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.9 | 53.9 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.9 | 1.8 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.9 | 8.9 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.9 | 81.4 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.9 | 76.7 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.9 | 44.9 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.9 | 27.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 2.5 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 7.3 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
0.7 | 15.2 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.7 | 8.6 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
0.7 | 16.5 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.7 | 7.3 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 2.7 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.6 | 31.7 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.6 | 21.0 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.6 | 28.2 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.6 | 9.1 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 14.4 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.6 | 6.3 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.6 | 3.3 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.5 | 10.4 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 2.1 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.5 | 4.3 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.5 | 1.6 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 3.9 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.5 | 7.2 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 13.4 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.5 | 4.8 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
0.5 | 2.3 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.5 | 6.1 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.5 | 33.5 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.5 | 3.2 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 15.2 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.4 | 3.6 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.4 | 9.3 | NABA_COLLAGENS | Genes encoding collagen proteins |
0.4 | 6.5 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 10.8 | PID_IGF1_PATHWAY | IGF1 pathway |
0.4 | 28.0 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.4 | 9.8 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.4 | 7.8 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.4 | 6.1 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 37.1 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 2.7 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 12.0 | PID_ATR_PATHWAY | ATR signaling pathway |
0.4 | 14.5 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 2.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 8.9 | PID_E2F_PATHWAY | E2F transcription factor network |
0.4 | 10.0 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 0.3 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
0.3 | 5.3 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 1.6 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 4.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.3 | 1.8 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.3 | 8.6 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.3 | 6.2 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.3 | 1.8 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 3.9 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 1.6 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
0.3 | 1.3 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 7.7 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.3 | 10.6 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 4.8 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.2 | 8.8 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.2 | 0.5 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 0.5 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 10.7 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
0.2 | 6.6 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.5 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.2 | 3.3 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.2 | 1.8 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 6.0 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.7 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.9 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.2 | 1.3 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 0.2 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.4 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
0.1 | 2.0 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.9 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.0 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
0.1 | 0.3 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 3.1 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 0.9 | PID_EPO_PATHWAY | EPO signaling pathway |
0.1 | 1.7 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.1 | PID_ATM_PATHWAY | ATM pathway |
0.1 | 0.2 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.3 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 6.3 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.5 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | PID_ARF6_PATHWAY | Arf6 signaling events |
0.0 | 1.2 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.3 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.0 | 0.3 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 15.1 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.7 | 1.7 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.6 | 49.4 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.6 | 37.8 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
1.6 | 43.9 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.5 | 20.9 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.5 | 1.5 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
1.2 | 40.9 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.2 | 24.5 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
1.1 | 35.8 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
1.1 | 9.6 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.1 | 6.4 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.0 | 24.9 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.9 | 8.9 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 20.4 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 7.9 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 17.6 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.9 | 1.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 3.5 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 14.5 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 13.6 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.8 | 5.1 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.8 | 35.3 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.8 | 16.7 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.8 | 83.8 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.8 | 22.9 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.8 | 4.7 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.8 | 0.8 | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.8 | 0.8 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.7 | 15.7 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.7 | 5.4 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.6 | 2.5 | REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 1.9 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.6 | 6.9 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 14.2 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.6 | 1.2 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.6 | 5.4 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 7.9 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.6 | 6.6 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.6 | 13.6 | REACTOME_KINESINS | Genes involved in Kinesins |
0.6 | 1.1 | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.6 | 17.8 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.6 | 7.2 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.5 | 4.8 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 4.8 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 3.7 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 24.8 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.5 | 5.7 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.5 | 3.1 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 10.6 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 19.4 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 1.4 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.5 | 24.8 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 13.9 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.4 | 0.9 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 3.5 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 3.5 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 8.6 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 9.2 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
0.4 | 5.6 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.8 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.4 | 3.6 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 1.2 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.4 | 0.4 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 7.4 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
0.4 | 2.5 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 3.9 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 1.4 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 1.0 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 11.2 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 0.7 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 7.7 | REACTOME_G2_M_CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.3 | 1.3 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.3 | 6.0 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.8 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 5.4 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.3 | 1.6 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 7.2 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 22.0 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.3 | 2.7 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 7.5 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.3 | 1.1 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 4.8 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 2.5 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.8 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 36.1 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.3 | 4.6 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 2.0 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 2.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.2 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 61.2 | REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.2 | 4.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 6.7 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 4.9 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.2 | 2.8 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.2 | 0.2 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
0.2 | 4.7 | REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.2 | 1.5 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 2.6 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.2 | 2.2 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 1.5 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 2.2 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.2 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.2 | 5.5 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.0 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 1.4 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.2 | 6.9 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 7.9 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.2 | 0.8 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 2.5 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 1.7 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.2 | 2.6 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 0.2 | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.2 | 1.5 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 2.9 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 7.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 0.5 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.1 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 13.5 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.2 | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.4 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 0.1 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.0 | REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 2.4 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.9 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.4 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.2 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.5 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 4.1 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.5 | REACTOME_DNA_REPAIR | Genes involved in DNA Repair |
0.1 | 1.0 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 0.2 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.2 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.0 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.4 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.5 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.0 | REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 1.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 0.8 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 2.1 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.6 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.4 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.0 | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.4 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 0.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.7 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.0 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.2 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 1.9 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 2.3 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 2.7 | REACTOME_INTERFERON_SIGNALING | Genes involved in Interferon Signaling |
0.0 | 0.4 | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.1 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 1.1 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.6 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.0 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |